73 related articles for article (PubMed ID: 12127077)
1. Cysteine 116 participates in intermolecular bonding of the human VEGF(121) homodimer.
Gaspar NJ; Jue RA; Hu J; Puchacz E; deForest NL; Schellenberger U
Arch Biochem Biophys; 2002 Aug; 404(1):126-35. PubMed ID: 12127077
[TBL] [Abstract][Full Text] [Related]
2. Expression of biologically active human vascular endothelial growth factor in yeast.
Mohanraj D; Olson T; Ramakrishnan S
Growth Factors; 1995; 12(1):17-27. PubMed ID: 8527160
[TBL] [Abstract][Full Text] [Related]
3. An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.
Siemeister G; Schirner M; Reusch P; Barleon B; Marmé D; Martiny-Baron G
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4625-9. PubMed ID: 9539788
[TBL] [Abstract][Full Text] [Related]
4. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency.
Keyt BA; Berleau LT; Nguyen HV; Chen H; Heinsohn H; Vandlen R; Ferrara N
J Biol Chem; 1996 Mar; 271(13):7788-95. PubMed ID: 8631822
[TBL] [Abstract][Full Text] [Related]
5. Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF.
Claffey KP; Senger DR; Spiegelman BM
Biochim Biophys Acta; 1995 Jan; 1246(1):1-9. PubMed ID: 7811723
[TBL] [Abstract][Full Text] [Related]
6. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.
Keck RG; Berleau L; Harris R; Keyt BA
Arch Biochem Biophys; 1997 Aug; 344(1):103-13. PubMed ID: 9244387
[TBL] [Abstract][Full Text] [Related]
7. The alpha-helical domain near the amino terminus is essential for dimerization of vascular endothelial growth factor.
Siemeister G; Marmé D; Martiny-Baron G
J Biol Chem; 1998 May; 273(18):11115-20. PubMed ID: 9556597
[TBL] [Abstract][Full Text] [Related]
8. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
9. Expression of biologically active isoforms of the tumor angiogenesis factor VEGF in Escherichia coli.
Siemeister G; Schnurr B; Mohrs K; Schächtele C; Marmé D; Martiny-Baron G
Biochem Biophys Res Commun; 1996 May; 222(2):249-55. PubMed ID: 8670191
[TBL] [Abstract][Full Text] [Related]
10. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
[TBL] [Abstract][Full Text] [Related]
11. The in vivo bioactivity of vascular endothelial growth factor/vascular permeability factor is independent of N-linked glycosylation.
Walter DH; Hink U; Asahara T; Van Belle E; Horowitz J; Tsurumi Y; Vandlen R; Heinsohn H; Keyt B; Ferrara N; Symes JF; Isner JM
Lab Invest; 1996 Feb; 74(2):546-56. PubMed ID: 8780172
[TBL] [Abstract][Full Text] [Related]
12. Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity.
Peretz D; Gitay-Goren H; Safran M; Kimmel N; Gospodarowicz D; Neufeld G
Biochem Biophys Res Commun; 1992 Feb; 182(3):1340-7. PubMed ID: 1540178
[TBL] [Abstract][Full Text] [Related]
13. Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations.
Pötgens AJ; Lubsen NH; van Altena MC; Vermeulen R; Bakker A; Schoenmakers JG; Ruiter DJ; de Waal RM
J Biol Chem; 1994 Dec; 269(52):32879-85. PubMed ID: 7806514
[TBL] [Abstract][Full Text] [Related]
14. Crystallization of the receptor binding domain of vascular endothelial growth factor.
Christinger HW; Muller YA; Berleau LT; Keyt BA; Cunningham BC; Ferrara N; de Vos AM
Proteins; 1996 Nov; 26(3):353-7. PubMed ID: 8953654
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor VEGF-like heparin-binding protein from the venom of Vipera aspis aspis (Aspic viper).
Komori Y; Nikai T; Taniguchi K; Masuda K; Sugihara H
Biochemistry; 1999 Sep; 38(36):11796-803. PubMed ID: 10512636
[TBL] [Abstract][Full Text] [Related]
16. Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells.
Ferrara N; Leung DW; Cachianes G; Winer J; Henzel WJ
Methods Enzymol; 1991; 198():391-405. PubMed ID: 1857232
[No Abstract] [Full Text] [Related]
17. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis.
Binétruy-Tournaire R; Demangel C; Malavaud B; Vassy R; Rouyre S; Kraemer M; Plouët J; Derbin C; Perret G; Mazié JC
EMBO J; 2000 Apr; 19(7):1525-33. PubMed ID: 10747021
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).
Tanaka K; Yamaguchi S; Sawano A; Shibuya M
Jpn J Cancer Res; 1997 Sep; 88(9):867-76. PubMed ID: 9369935
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and vasculogenesis in treatment of cardiovascular disease.
Rivard A; Isner JM
Mol Med; 1998 Jul; 4(7):429-40. PubMed ID: 9713822
[No Abstract] [Full Text] [Related]
20. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.
Myoken Y; Kayada Y; Okamoto T; Kan M; Sato GH; Sato JD
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5819-23. PubMed ID: 1712106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
